Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05533372 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05533372 · ClinicalTrials.gov record · last posted 2026-08-19

MAD Study of IA-14069

StatusCompleted
PhasePhase 1
Started2022-10-10
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending oral doses of IA-14069 in healthy subjects and in patients with RA on stable dosese of MTX, with preliminary assessment of efficacy in RA patients.

Protocol amendment history 2 changes detected by DataLookout

2026-08-20
Trial completed
2026-08-20
Completion moved earlier: 2026-02 → 2025-10-15
Trial Details
NCT Number NCT05533372
Lead Sponsor ILAb Co., Ltd.
Conditions Healthy, Rheumatoid Arthritis
Enrollment 78 participants
Start Date 2022-10-10
Primary Completion 2025-10-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-08-19